UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009507
Receipt number R000011171
Scientific Title The effect of rebamipide for the protection of the oral mucositis in the breast cancer patients
Date of disclosure of the study information 2012/12/09
Last modified on 2019/03/22 16:21:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of rebamipide for the protection of the oral mucositis in the breast cancer patients

Acronym

Cinderella-01

Scientific Title

The effect of rebamipide for the protection of the oral mucositis in the breast cancer patients

Scientific Title:Acronym

Cinderella-01

Region

Japan


Condition

Condition

bresat cancer

Classification by specialty

Hematology and clinical oncology Breast surgery Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

examination of the effect of rebamipide for the protection of the oral mucositis during the chemotherapy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

rate of the oral mucositis over grade 1

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

rebamipide

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >=

Gender

Female

Key inclusion criteria

1. early breast cancer
2. planned FEC or TC chemotherapy on the neo or post-operation adjuvant chemotherapy
3. no treatment for BC
4. normal organ function
5. writtten IC

Key exclusion criteria

1. difficult in the oral administration
2. metastatic of reccurent Brast cancer

Target sample size

160


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name norikazu masuda

Organization

Cinderella study group

Division name

NHO Osaka national Hsp

Zip code


Address

2-1-14,houenzaka, Chuou-ku, Osaka

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Cinderella study group

Division name

NHO Osaka national Hsp

Zip code


Address


TEL


Homepage URL


Email

nmasuda@alpha.ocn.ne.jp


Sponsor or person

Institute

Cinderella study group

Institute

Department

Personal name



Funding Source

Organization

Sakai Clinical support center

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 12 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 04 Month 22 Day

Date of IRB

2011 Year 05 Month 31 Day

Anticipated trial start date

2011 Year 06 Month 01 Day

Last follow-up date

2015 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 12 Month 09 Day

Last modified on

2019 Year 03 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011171


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name